CompletedPhase 4ketamine

Effect of S-ketamine in Cesarean Section Combined Anesthesia

Sponsored by The Second Affiliated Hospital of Chongqing Medical University

NCT ID
NCT05414006
Target Enrollment
120 participants
Start Date
2022-06-14
Est. Completion
2022-09-05

About This Study

To compare the anti-hyperalgesia effect between S-ketamine with placebo for Maternal receiving elective Cesarean Section under Combined spinal and epidural analgesia. Based on this study the investigators intend to verify the role and potential mechanism of S-ketamine combined anesthesia in alleviating hyperalgesia after cesarean section, prove that it can reduce hyperalgesia and postoperative pain. explore the role of S-ketamine in alleviating postoperative hyperalgesia in different PCA ways and explore the safety of S-ketamine in the perilactation

Conditions Studied

Postoperative Pain

Interventions

  • S-ketamine

Eligibility

Sex:FEMALE
Age:20 Years - 45 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* ASA status I-III
* Age 20 to 45
* 37-42 weeks gestation
* undergo elective cesarean section with subarachnoid anesthesia
* participate in this study and sign informed consent

Exclusion Criteria:

* Patients with contraindications for cesarean section
* Patients with contraindications of combined spinal and epidural anesthesia
* Patients with severe systemic disease
* Alcoholism and long-term use of anti-inflammatory and analgesic drugs
* Patients who were unable to cooperate or refused to participate in the trial
* Patients with contraindications to esketamine and hydromorphone

Study Locations (1)

Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Effect of S-ketamine in Cesarean Section Combined Anesthesia | Huxley